Novanta Inc(NOVT) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 14 at 6:54 PM ET (Korea 9/15 07:54)
Full metrics table
| Index | RUT | P/E | 89.52 | EPS (ttm) | 1.56 | Insider Own | 0.75% | Shs Outstand | 37.8M | Perf Week | -5.6% |
| Market Cap | 5.30B | Forward P/E | 32.07 | EPS next Y | 18.23% | Insider Trans | -10.56% | Shs Float | 37.5M | Perf Month | -16.26% |
| Enterprise Value | 4.86B | PEG | - | EPS next Q | 0.97 | Inst Own | 120.46% | Short Float | 13.03% | Perf Quarter | -12.76% |
| Income | 0.06B | P/S | 5.14 | EPS this Y | 12.26% | Inst Trans | 24.22% | Short Ratio | 10.69 | Perf Half Y | 19.95% |
| Sales | 1.03B | P/B | 3.28 | EPS next 5Y | - | ROA | 3.38% | Short Interest | 4.89M | Perf YTD | 17.7% |
| Book/sh | 42.75 | P/C | 7.37 | EPS past 3/5Y | -10.74% 2.97% | ROE | 5.11% | 52W High | -20.6% ($176.38) | Perf Year | 22.28% |
| Cash/sh | 19 | P/FCF | 46.78 | Sales past 3/5Y | 4.43% 10.67% | ROIC | 3.34% | 52W Low | 42.52% ($98.27) | Perf 3Y | -11.53% |
| Dividend Est. | - | EV/EBITDA | 26.79 | EPS Y/Y TTM | -7.28% | Gross Margin | 41.9% | Volatility(W/M) | 2.72% 3.62% | Perf 5Y | -6.67% |
| Dividend TTM | - | EV/Sales | 4.72 | Sales Y/Y TTM | 7.61% | Oper. Margin | 11.65% | ATR (14) | 5.91 | Perf 10Y | 734.62% |
| Dividend Ex-Date | - | Quick Ratio | 3.79 | EPS Q/Q | 144.54% | Profit Margin | 6% | RSI (14) | 40.33 | Recom | 1.25 |
| Dividend Gr. 3/5Y | - | Current Ratio | 4.57 | Sales Q/Q | 10.27% | SMA20 | -4.34% ($146.4) | Beta | 1.72 | Target Price | $194.5 |
| Payout | - | Debt/Eq | 0.18 | Earnings | 2026/8/5 | SMA50 | -6.43% ($149.67) | Rel Volume | 0.74 | Prev Close | $146.56 |
| Employees | 3000 | LT Debt/Eq | 0.14 | EPS/Sales Surpr. | 7.23% 1.34% | SMA200 | 1.01% ($138.65) | Avg Volume(3M) | 0.46M | Price | $140.05 |
| IPO | 1995/9/22 | Option/Short | Yes/Yes | Trades | 10732 | Volume | 337,179 | Change | -4.44% |
Company
NOVT is a Technology sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
🔬 This U.S. technology company supplies precision optics, vision, and motion components used in medical and advanced industrial equipment. It provides precision components such as laser and optical scanning systems, precision motion control, and machine vision to medical and industrial equipment manufacturers, making it a precision instruments play whose results are tied to medical and automation demand, new orders, and acquisitions.
Over the past 1 year, roughly in the middle
21% below its 1-year high.
NOVT makes money exceptionally well
11.65% of revenue is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +12.3% this year.
Tap to view numbers
The price looks about right
Trading at 89.5 times earnings.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 3 quarters.
Tap to view numbers
The outlook is positive
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Would have changed by -11.5% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership is about average
Institutions hold 120.5%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
KNOW 0.03%
BOUT 0.03%
CSMD 0.02%
KOID 0.02%
ALIL 0.02%It ranks #4 in the industry
Based on market cap of $5B.
NOVT $5B PER 89.5
GRMN $54B PER 28.9
KEYS $54B PER 43.4
COHR $52B PER 64.8
FAQ
What kind of company is NOVT?
NOVT belongs to the Technology sector and operates in the Scientific & Technical Instruments industry.
What is the market cap of NOVT?
The market cap of NOVT is approximately $5.3B, ranking 1,345 within its sector.
What is the P/E ratio of NOVT?
NOVT has a P/E ratio of approximately 89.5x, which can be used to assess its valuation relative to the Technology sector average.
What is the 52-week high and low for NOVT?
NOVT has recorded a 52-week high of $176.38 and a low of $98.27.
